# Session Transfer — CareRelay

Research snapshot: **17 September 2026**. Workspace: `C:\Users\jayd0\OneDrive\Desktop\ai-triage`.

This handoff preserves an independent review and its unresolved improvement questions. It supplements, rather than silently endorses, `docs/PLAN.md`. The user requested this document and a separate copy-paste prompt; the user has **not approved the reviewer's hybrid recommendation or implementation**.

Evidence labels: **[verified]** = supported by the cited source as of the research date, including vendor-documented capabilities; **[overstated]** = stronger than the evidence supports; **[unknown]** = not established. Vendor documentation is not independent clinical validation. Scores and proposed directions are reviewer judgments, not verified facts. All external sources below were accessed on 17 September 2026, not freshly rechecked when this handoff was written.

## Completed

- An independent review covered event requirements, all seven traps and all open items in `docs/PLAN.md`, Tencent integration surfaces, competitors, recent developments, Singapore routing, both medical case studies, three ambitious directions, and a ten-dimension rubric estimate.
- Every file then in the requested folder was read: `AGENTS.md`, `docs/CHALLENGE_REQUIREMENTS_JUDGING.md`, `docs/ADDITIONAL_CHALLENGE_INFO.md`, `docs/PLAN.md`, `medical-ai-framework_casestudy1.md`, and `ai-triage_casestudy2.md`. No implementation, evaluation harness or submission assets were present. No files were changed during the review.
- The original 41-page handbook was absent locally but recovered from Tencent's public resource site. Its page references are no longer automatically unknown. The original transcript filenames cited by the older plan remain absent; speaker identity and exact transcription fidelity remain unknown.
- The Mount Sinai public abstract, publication date and disclosures were independently accessible. Full figures required sign-in, so the digest's figure values were not independently authenticated. Arithmetic was recomputed from the digest.
- Parallel primary-source research covered event/local rules, Tencent runtimes/voice, and competitors. Key scheduler constraints, recent recovery announcements, paper metrics and numerical calculations were separately checked.

## Decisions

### Decision status and reviewer verdict

- The existing target is **Healthcare Challenge 1 — AI Grandma Knows Best: Intelligent Self-Triage and Care Navigation**. The recovered one-case-study rule supports retaining one declared challenge, rather than presenting a Challenge 1+2 combination.
- **Reviewer recommendation: HYBRID, moderate confidence.** CareRelay's problem remains useful, but broad failed-plan recovery is already commercially occupied. The recommendation was an accountable recovery workflow plus one narrowly tested assessment/comprehension mechanism, not three combined products.
- This is **not a user-approved pivot or implementation specification**. The user asked to preserve the analysis and expand the open improvement agenda.
- The strongest case for CareRelay is the gap between understanding advice and being able to act on it. The strongest case against it is that the current artifacts establish neither working integration nor differentiated behaviour, and clinical scope/reviewer/access/evaluation remain unresolved.
- The preferred differentiation hypothesis is **testable recovery behaviour**, not an asserted empty market: operational retries do not silently downgrade clinical urgency, restart the action deadline, or falsely report care as completed.
- The review retained the previous plan's synthetic-data and visibly simulated-integration scope. No institutional integration, booking access or clinician commitment has been established.

### Requirements clarified by recovered primary evidence

**H** = [official 41-page handbook](https://heikesong-global-1256915710.cos.ap-hongkong.myqcloud.com/online_video/27098f4f-7e3b-4e7a-874d-d94ee8ac36ba.pdf), linked from [Tencent Resources](https://tch.tencentcloud.com/empower). A [second officially listed copy](https://heikesong-global-1256915710.cos.ap-hongkong.myqcloud.com/online_video/c1b7982c-2730-4fc5-aa8f-7e540f8b1628.pdf) and [organizer kickoff announcement](https://luma.com/26fqf3hy) were also located.

| Review finding | Evidence and qualification |
|---|---|
| [verified] Co-hosts: Tencent Cloud and AI Singapore; healthcare contributor: NTU LKCMedicine | H pp2,27. NHG's specific hackathon organizing/judging role remains [unknown]. |
| [verified] Teams of 1–3, participants based in Singapore, one registration per team | H p37. Citizenship-only or students-only restrictions would be [overstated]. |
| [verified] Each team selects only ONE case study and identifies it at presentation start | H p27; supports the Challenge 1-only target. |
| [verified] Submission 16 October 2026; finalist announcement 23 October; Demo Day 3 November, TBC | H p36. Exact submission cutoff time/time zone [unknown]. The review date was 17 September, giving 29 days to submission; that countdown is not evergreen. |
| [verified] Original project built on at least one of CodeBuddy or WorkBuddy, with mandatory usage proof | H p35. Without proof the project does not proceed to scoring. Technical exclusivity is not required. |
| [overstated] Logs or a written description necessarily replace all screenshot requirements | The general proof paragraph offers alternatives, but H p35 separately requires development conversation history and at least three chat screenshots. The review recommended satisfying the screenshot checklist regardless. |
| [verified] Generic rubric: ten dimensions, ten points each | H p38; healthcare-specific detailed criteria are promised after registration. Treating the public rubric as complete is [overstated]. |
| [verified] 1,000 CodeBuddy/WorkBuddy credits per person are offered | H p39. Redemption, expiry, allocation between products and whether any other cloud services are covered remain [unknown]. |
| [overstated] Every listed behaviour is a separate mandatory pass/fail feature | H pp28–30 and `docs/CHALLENGE_REQUIREMENTS_JUDGING.md:26–47` describe the list as guidance and permit meaningful alternatives. The behaviours remain the strongest published alignment signals. |
| [overstated] The example scenarios are validated clinical protocols, or MIMIC/Kaggle is mandatory | H pp29–30. Examples and dataset suggestions do not establish safe local thresholds, licensing, access or a requirement to train a model. |

The submission interpretation from the review was: title; **blurb under 10 words**; description covering users/scenario/pain points, business and technical architecture, prompt usage and impact; development conversation history; **at least three screenshots**; **16:9 cover image** (recommended 380×216); and Challenge 1's live walkthrough, architecture/trust-boundary diagram and GitHub source. A **5–8-minute video** and live link are optional, with the link described as earning bonus points. H pp30,35 and `docs/CHALLENGE_REQUIREMENTS_JUDGING.md:124–169` are the evidence.

There is a wording conflict between the generic table's optional challenge-specific extras and Challenge 1's listed deliverables. The review recommended providing them rather than relying on the weaker wording; organizer clarification has not occurred.

### Organiser-tech assessment

The user's hypothesis is that a project buildable without WorkBuddy/CodeBuddy is the wrong project for this hackathon. The review found this **stricter than eligibility**: meaningful built-on usage and proof are required, not irreplaceability. Deeper integration could improve AI Interaction and Technical Execution, but unnecessary enterprise dependencies or delayed emergency routing could hurt Feasibility and Responsible AI.

| Surface | Verified research result | Current CareRelay status / caveat |
|---|---|---|
| WorkBuddy managed agents | [Documentation portal](https://www.codebuddy.cn/apiDocs/cloud-agent.html), [Node SDK](https://www.codebuddy.cn/apiDocs/cloud-agent-sdk-api-Node%20SDK.md), [Python SDK](https://www.codebuddy.cn/apiDocs/cloud-agent-sdk-api-Python%20SDK.md): programmatic agents, versions, runtimes, streaming sessions | Proposed coordinator, not demonstrated integration. Packages are `@tencent-ai/cloud-agent-sdk` and `codebuddy-cloud-agent-sdk`. |
| MCP, skills, hooks | [AgentOS OpenAPI](https://www.codebuddy.cn/apiDocs/agentos-api.yaml) and SDKs document tool/skill configuration and events including tool failures | No ready-made healthcare connector, clinic access or approved human callback integration was established. |
| Sessions and checkpoints | Documented creation/restoration facilities | Not clinical records, external-action rollback, exactly-once execution or evidence that care occurred. |
| Managed scheduling | AgentOS `ownerType` is fixed to `enterprise`; enterprise ID comes from authentication; recurring interval is at least five minutes; manual triggers are limited to once/minute/task; executions create new sessions | Constraint belongs to this managed API, not automatically every desktop scheduler. Emergency instructions must not depend on it. Application state cannot rely on a single conversation persisting. |
| CodeBuddy Agent SDK | [SDK documentation](https://www.codebuddy.ai/docs/cli/sdk): embeddable agent execution, MCP, hooks, permissions and restoration; Preview; invokes CodeBuddy CLI | More than an IDE build assistant. Could have a larger runtime/testing role, but this is a host-running SDK rather than WorkBuddy managed cloud. Filesystem settings/skills are not loaded by default; `settingSources` matters. |
| Miora | [Tencent May 28 announcement](https://www.tencent.com/en-us/articles/2202341.html): creative studio for graphics, interfaces, video and other assets | General coordination API/runtime [unknown]. Miora alone is not an eligible substitute for CodeBuddy/WorkBuddy. A larger role is justified by better tested design, not product-name counting. |
| ADP | [July 21 ADP 4.0 announcement](https://www.tencentcloud.com/dynamic/news-details/101401): workflows, agent infrastructure, Skills and Claw Mode sandbox execution | Distinct from WorkBuddy; no shared entitlement assumption. |
| Agent Runtime | [Overview](https://cloud.tencent.com/document/product/1814/129423), [API history](https://cloud.tencent.com/document/product/1814/124834): isolated execution, runtime/state/credential infrastructure | Handbook startup/concurrency claims are vendor descriptions, not measured CareRelay performance. |
| TRTC voice | [Native ASR](https://trtc.io/document/80841) lists 30 languages; [native TTS](https://trtc.io/document/79682) documents Chinese, English and Cantonese | ASR coverage is not TTS coverage. Tamil was not in the reviewed native ASR list. General-purpose language support does not establish clinical accuracy for Singapore accents. |
| Additional voice providers | [Soniox integration](https://trtc.io/document/79675) supports code-switching; [TTS provider integrations](https://trtc.io/document/68340) have provider-specific requirements | Separate provider keys/billing may apply. Text confirmation/fallback and medical-vocabulary testing remain unresolved. |

Other access risks recorded: mainland `.cn` documentation versus international availability; SDK `x-api-key` versus general OpenAPI Bearer authentication descriptions; package/documentation version skew; quotas/lifetimes; permitted models; callback semantics; data residency and billing. [npm](https://registry.npmjs.org/@tencent-ai%2Fcloud-agent-sdk) listed Node 0.3.8 dated June 22 while SDK documents identified v0.3.4; [PyPI](https://pypi.org/pypi/codebuddy-cloud-agent-sdk/json) listed Python 0.3.4 dated June 22. These were research snapshots, not authenticated tests.

The reviewer proposed a practical dependency test: without WorkBuddy, coordination, tool execution and episode resumption would stop rather than merely lose a logo. A real failed-tool result followed by an allowed alternative and consent would be stronger evidence than a hard-coded interface sequence. Authoritative clinical urgency and action records would remain outside the LLM. This design has not been approved or built.

### Competitive position and recent changes

**No market vacancy was established.** Public documentation also did not establish an exact equivalent guarantee covering unchanged clinical deadlines, failed transfers, evidence-backed completion and every retry transition. Neither absence nor superiority is proven.

| Competitor | Primary evidence and consequence |
|---|---|
| KKH U-PAL | [Current official service](https://www.kkh.com.sg/clinic-visit/emergency-care/upal) documents free 24/7 paediatric guidance, generative AI and emergency routing. Midnight-parent triage is already served locally; exact recovery semantics [unknown]. |
| Infermedica | [Follow-up](https://infermedica.com/solutions/follow-up) documents linked reassessments and symptom tracking. [June 18 Healthdirect/ChatGPT announcement](https://www.einpresswire.com/article/920486710/healthdirect-australia-infermedica-and-partners-collaborate-on-chatgpt-health-service-pilot?n=2) covers navigation/appointments and a nurse-handover vision, but describes a pilot, not nationwide deployment. |
| Clearstep | [Platform](https://www.clearstep.health/) and [navigation](https://www.clearstep.health/smart-access-care-navigation) document triage, voice, scheduling and care-management workflows. A claim that competitors stop at advice is stale. |
| Ada / Sutter | [Sutter case study](https://ada.com/improving-care-navigation-at-sutter-with-ai/) documents navigation and booking engagement. [April 13 clinical safety-layer announcement](https://about.ada.com/press/patent-llm-clinical-safety-layer/) separates clinical reasoning from the LLM. New Ada capabilities are not automatically verified Sutter deployment features. |
| Hippocratic AI / UHS | [June 16, 2025 joint deployment announcement](https://hippocraticai.com/universal-health-services-launches-hippocratic-ais-generative-ai-healthcare-agents-to-assist-with-post-discharge-patient-engagement/) documents instruction review, worsening-symptom checks and nurse callbacks. This is not a new 2026 idea. |
| Hippocratic AI orchestrators | [August 13, 2026 announcement](https://www.prnewswire.com/news-releases/hippocratic-ai-announces-next-generation-of-healthcare-ai-orchestrators-focused-on-outcomes-not-tasks-302850620.html), [Front Door](https://hippocraticai.com/ai-front-door/), [recovery](https://hippocraticai.com/ai-lost-to-follow-up-provider/), and [readmission](https://hippocraticai.com/ai-readmission-provider/) describe barrier-sensitive alternatives, caregiver support, documented loops and live escalation. Some transportation features are labelled potential. Formal deadline/urgency guarantees [unknown]. |
| Luma | [September 15, 2026 announcement](https://www.prnewswire.com/news-releases/luma-expands-ai-powered-patient-outreach-giving-health-systems-more-ways-to-close-care-gaps-and-fill-schedules-302878270.html) documents cancellation/no-show recovery and EHR rebooking. CLS's 2.3× result concerns rescheduled cancelled appointments, not clinical outcomes. Referral scheduling is coming soon. |
| Synapxe / HealthHub | [July 2 consolidation announcement](https://www.synapxe.sg/media-releases/collaboration/healthcare-apps-unified-healthhub-2026) targets November 2026, not a completed launch. [Caregiver delegation](https://www.healthiersg.gov.sg/enrolment/addcaregiver/) already exists; a September page update does not establish a September feature launch. |
| PathWISE | [Authors' preprint](https://arxiv.org/abs/2605.25970), revised June 3, confines LLM inference to knowledge extraction with deterministic compilation/auditing. Research prior art, not deployed patient recovery or proof of clinical safety. |
| Trisotech | [Decision demonstration](https://www.trisotech.com/can-you-trust-an-llm/) and [care-plan discussion](https://www.trisotech.com/caring-about-care-plans/) establish deterministic decisions, responsibility assignment and orchestration as prior art. Demonstrations are not fully enforced production guarantees. |

The dated timing assessment was:

| Shift | Classification | Consequence for CareRelay |
|---|---|---|
| June 2 Soniox and June 16 Inworld/Tencent voice announcements | Makes-this-easier | [Soniox](https://soniox.com/blog/tencent-partnership-announcement) and [Inworld](https://www.tencentcloud.com/dynamic/news-details/101293) reduce voice-integration effort; no account or clinical-accuracy guarantee. |
| June 3 PathWISE revision | Makes-this-obsolete: architecture novelty | LLM interpretation plus deterministic clinical logic is sensible but established. |
| June 18 Healthdirect pilot | Makes-this-obsolete: generic chat-to-care novelty | Local navigation and human handover already have platform-level competition; pilot status matters. |
| July 15 Mount Sinai publication | Makes-this-obsolete: broad integrated-triage novelty | New publication about an older 2023 deployment, not a July product launch. |
| July ACL MedQAbstain | Makes-this-easier: evaluation | [Paper](https://aclanthology.org/2026.acl-long.1365/) and [code](https://github.com/disi-unibo-nlp/llm-medical-abstention) expose overcommitment under uncertainty. Medical QA benchmark, not a triage validation set. |
| July 21 ADP 4.0 | Makes-this-easier | Long-running sandbox workflows are more accessible within Tencent, without proving WorkBuddy entitlement or industry-first capability. |
| August 5 wider Hy3 availability | Makes-this-easier | [Tencent announcement](https://www.tencent.com/tencent-hy3-now-available-globally-extending-practical-ai-across-products-workflows-and-cloud-services/) expands access; advertised free WorkBuddy promotion ended August 31. |
| August 13 Hippocratic / September 15 Luma | Makes-this-obsolete: broad recovery novelty | These are the strongest recent challenges to the original gap claim. |

The strongest counter-position was that being early now could mean **actively improving unreliable patient observations and measuring when the system must refuse to decide**, rather than adding more follow-up automation. No recent platform release was found to establish safe autonomous clinical disposition.

### Three directions considered, not approved

| Direction | Pitch and smallest demonstration | Technology, prior art and principal risk |
|---|---|---|
| CareRelay: accountable care episode | An episode stays unresolved until the next step has appropriate evidence or a visible failure. One scenario, three barriers (clinic unavailable, caregiver unavailable, misunderstood instructions), persistent deadline and labelled simulated confirmations. | WorkBuddy coordination plus CodeBuddy-built tests. At least four strong adjacent offerings: Hippocratic AI, Luma, Clearstep, Infermedica. Risk: implying completed care or clinical safety from workflow execution. |
| GuidedCheck: trustworthy observations | A non-CareRelay-shaped alternative: a spoken, accessible observation process instead of guessing from vague symptoms. One scenario, user-confirmed measurement, contradiction detection and deliberate abstention. | TRTC voice and bounded WorkBuddy assessment skills. [TytoCare](https://www.tytocare.com/) and [UCSD protocol-grounded triage research](https://today.ucsd.edu/story/new-conversational-ai-tool-uses-trusted-medical-protocols-to-help-people-decide-when-to-seek-care) are adjacent prior art. Risk: treating unreliable observations as objective evidence; no ordinary-video vital-sign or rash-diagnosis claim. |
| Family Interpreter: shared multilingual triage | Patient and caregiver speak different languages while source attribution and disagreement stay visible. Two languages, two roles, critical-fact confirmation and simulated human takeover. | TRTC plus WorkBuddy sessions/tools; [Lexi](https://www.withlexi.com/), [No Barrier](https://www.nobarrier.ai/post/ai-in-medical-translation-capabilities-and-limitations), and [Dora multilingual follow-up research](https://pmc.ncbi.nlm.nih.gov/articles/PMC13392653/) establish adjacent work. Risk: fluent mistranslation and consent failures. |

Reviewer ranking: CareRelay's accountable recovery first for demo/theme balance, GuidedCheck second as the more ambitious assessment alternative, Family Interpreter third because translation alone is crowded. Current integrated tools make small-team slices more feasible; none of these categories was established as newly invented or competitor-free. The Dora source was a seven-person Turkish-speaking focus-group study published July 22, not proof of a deployed multilingual triage service.

### Rubric estimate from the review

These are subjective planning estimates, not official scores or credit for implementation that does not exist. The current folder alone would not meet the mandatory usage-proof gate. The second column assumes substantive delivery and evidence, not merely revised wording.

| Dimension | As-is /10 | Conditional improved /10 | Basis |
|---|---:|---:|---|
| Impact & Relevance | 8 | 8 | Clear problem, target-population benefit unmeasured. |
| Human-Centered Design | 6 | 8 | Plausible caregiver barriers without observed users. |
| AI Interaction | 5 | 8 | Runtime role asserted, not demonstrated. |
| Technical Execution | 3 | 8 | Good separation principle, no implementation or failure tests. |
| Feasibility | 5 | 7 | Bounded slice plausible; clinical and account dependencies unresolved. |
| Demo & Storytelling | 6 | 9 | Recovery failures could make a memorable demonstration. |
| Innovation & Creativity | 4 | 6 | Broad category crowded; tested safety semantics could differentiate. |
| UX & Accessibility | 4 | 8 | No tested interface, language or accessibility evidence. |
| Responsible AI & Ethics | 7 | 8 | Strong design intentions; calibrated abstention and subgroup evidence absent. |
| Overall Quality & Judge's Impression | 6 | 8 | Coherent direction, under-evidenced. |
| **Total** | **54/100** | **78/100** | Neither total predicts placement or the undisclosed healthcare rubric. |

The improved Innovation score of only 6 and Feasibility score of 7 are **not accepted ceilings**. The next substantive improvement analysis has not occurred; the user specifically wants these and the other dimensions examined more deeply.

Evidence that would strengthen continuation: demonstrated runtime access, clinician-reviewed boundaries, observed target-user need, and tests showing no inappropriate deadline resets, operational downgrades or false completion claims. Evidence favouring a pivot: the target users do not experience the proposed barrier, an accessible incumbent solves it adequately, or a credible clinical-review/integration path is unavailable. Evidence favouring GuidedCheck: obtaining/interpreting symptoms proves more important than executing the resulting recommendation.

## Traps

### All seven traps from the older plan, adjudicated

1. **Reason2Decide's 96% is PubMedQA accuracy, not triage accuracy — [verified].** Temptation: turn a research benchmark into CareRelay clinical validation. Further corrections appear below.
2. **Managed scheduler enterprise ownership and five-minute minimum — [verified] for AgentOS.** Temptation: place urgent escalation on scheduled jobs, or generalize these restrictions to every WorkBuddy interface.
3. **Illustrative scenarios are not validated local protocols — [verified].** Temptation: copy fever/COVID thresholds, drug doses or the example's 911 routing.
4. **Miora alone is not the explicit eligibility route — [verified].** Temptation: equate a recommended design tool with the CodeBuddy/WorkBuddy requirement.
5. **Built-on does not mean technically exclusive — [verified].** Temptation: force avoidable complexity to claim the project is impossible without Tencent.
6. **A recommendation reportedly preceded PDF discovery — [unknown] historical claim.** Temptation: present the older session's account as independently reconstructed. This review enumerated the folder and recovered the handbook online.
7. **Triage, follow-up, navigation and comprehension support have prior art — [verified] broadly.** Temptation: rebrand any one ingredient as novel, or equate marketing capability with validated outcomes.

### Additional corrections that change the design

- **Urgency versus reassessment:** operational inconvenience must not lower urgency; a fresh, clinically justified reassessment may change disposition. The previous blanket wording could conflict with dynamic reassessment. A new decision would need its own evidence/version, not a hidden overwrite.
- **Deadline preservation:** retaining an urgency label while restarting its clock is not preservation. The review proposed an absolute clinical action deadline across operational retries.
- **Progress versus evidence:** `proposed → accepted → self-reported → externally verified` mixes different dimensions. The review proposed separate execution status and evidence status. Booking confirmation proves booking, not attendance; caregiver acceptance proves agreement, not care. [FHIR Task](https://hl7.org/fhir/R4/task.html) is prior art for task lifecycles; state names alone are not innovation.
- **Rules are not sufficient safety evidence:** a deterministic engine can confidently use an incorrectly extracted symptom or an unsafe rule. Input interpretation, missing information, contradiction and critical-fact confirmation remain safety boundaries.
- **Human handoff is not a magic endpoint:** a transfer attempt can fail, time out or remain unacknowledged. No real receiving clinical service or availability commitment has been established.
- **Simulation versus truth:** external confirmation in a simulated integration is still simulated. A successful tool call, caregiver acknowledgement or restored checkpoint does not prove care occurred.
- **Source-template carryover:** the handbook includes banking language, game-quality wording and 911. The local TRTC descriptions include banking/transaction examples. These are not validated healthcare workflows.

### Medical evidence corrections

[Reason2Decide full paper](https://arxiv.org/html/2512.20074v2), [LREC record](https://lrec.elra.info/lrec2026-main-181), and [official code repository](https://github.com/quamranhasan/Reason2Decide):

- [verified] T5-Large triage macro-F1 is **60.58 ± 0.46** on private Alberta Health Link 811 data. The roughly 171k figure is the training split, with separate validation/test splits.
- [verified] PubMedQA **96.05% accuracy / 60.28 macro-F1** uses a test set of 10,000 artificially generated examples plus 1,000 human-labelled examples; it is not just the standard human-labelled set.
- [verified] Task-level scheduled sampling moves rationale conditioning from gold labels toward model predictions, capped at 90%. Explanations are conditioned on the model's prediction at inference.
- [overstated] This eliminates hallucinated rationales or proves causal faithfulness. Prediction-consistent explanation does not establish correct prediction or access to the model's true decision process.
- [overstated] The model is proven 40× smaller than GPT-4. The supported comparison is with a 32B comparator, not a verified GPT-4 size.
- [verified] The public repository includes training/inference code and processed public QA datasets, not the private triage data or a ready-to-use clinical checkpoint. The broader absence of any checkpoint anywhere was not proved.
- [verified] Rationale evaluation lacked human oversight; the paper requires human verification. Broad claims that synthetic rationales replace human annotation or establish clinical deployment readiness are unsupported.

The older plan's ChatGPT Health warning is supported by a [Nature Medicine study](https://www.nature.com/articles/s41591-026-04297-7) and [author-affiliated abstract record](https://cris.tau.ac.il/en/publications/chatgpt-health-performance-in-a-structured-test-of-triage-recomme/): a **structured stress test with 60 clinician-authored vignettes and 960 responses**, reporting 52% undertriage in emergency cases. It is not a measured harm rate in deployed patients, nor a universal error rate for every LLM. The publication is February 2026, outside the requested June–September frontier window.

[Mount Sinai article](https://catalyst.nejm.org/doi/full/10.1056/CAT.25.0394): publication **15 July 2026**, public abstract checked; full figures unavailable without sign-in. Local detailed evidence is in `ai-triage_casestudy2.md`.

| Numerical issue | Independent result and remaining uncertainty |
|---|---|
| >60,000 visits / ~22,000 completions / 37% initiation / ~80% completion | Calling this irreconcilable is [overstated]. Approximately 74,324 visits reconciles the rates and still exceeds 60,000. The digest's 74,692 daily-count total would imply ~22,109 completions. Actual shared denominator/window remains [unknown]. Local lines 139–144,426–433. |
| 33% CTA versus 38.5% | Different bookable-care versus overall denominators could explain this; [unknown], not demonstrated contradiction. Local lines 195–213. |
| Weekend share 26% | Digest counts imply 16,661 / 74,692 = **22.31%**. Arithmetic mismatch [verified]; original figure transcription [unknown]. Local lines 215–229. |
| At least 8/10 ratings reportedly >75% | Digest counts imply 547 / 871 = **62.80%**; original figure transcription [unknown]. The public abstract separately reports approximately 75%. Local lines 246–263. |
| Female-to-male ratio reportedly 2.58 | Digest percentages imply 31.23 / 12.74 = **2.45**. Additional arithmetic mismatch in the digest; original figure verification unavailable. Local lines 236–241. |

Other evidence boundaries: the **51% confirmed-booking result belongs to another delivery network**, not Mount Sinai; CTA is not booking, attendance or outcome; zero reported incidents is not proof of zero harm; concordance is not demonstrated reduction in mortality, cost or emergency use. The article discloses vendor-linked authors. The evidence supports an integrated implementation account, not unqualified headline claims (`ai-triage_casestudy2.md:312–358,408–424`).

Mechanisms worth reusing are separation of language interpretation from deterministic disposition, user confirmation of the interpreted complaint, explanations grounded in the actual decision trace, pre-triage intended-action measurement, and careful conversion/outcome instrumentation. These are established mechanisms, not novel claims. Wholesale copying of licensed Schmitt–Thompson protocols is outside the proposed scope: [rights holder](https://www.stcc-triage.com/). [HSA digital-health guidance](https://www.hsa.gov.sg/medical-devices/digital-health/) also means that saying “not diagnosis” does not automatically remove medical-device considerations.

### Singapore and contributor facts that must not become stale assumptions

- [verified] [SCDF](https://www.scdf.gov.sg/home/about-scdf/emergency-medical-services): **995** is for emergencies; A&E prioritizes severity, not ambulance arrival; ambulance conveyance is to an appropriate designated hospital, not a freely selected destination.
- [verified, time-sensitive] [MOH](https://www.moh.gov.sg/newsroom/1777-non-emergency-ambulance-hotline-to-cease--from-1-january-2027/): **1777 ceases from 1 January 2027**. It arranges non-emergency ambulance transport, not clinical triage advice. Permanent hard-coding would be wrong.
- [verified] [CHAS](https://www.chas.sg/About-CHAS) is a subsidy scheme, not a clinical disposition or universal entitlement; GP/polyclinic are care venues. [HealthHub](https://www.healthhub.sg/) is an access/directory/records layer, not another urgency level.
- [verified] [MOHT's NurseFirst account](https://www.moht.com.sg/blog/transforming-pre-hospital-emergency-care/) documents human triage and escalation. Its existence does not establish automated integration permission, a receiving-service commitment or API access.
- [verified] [NTU C-AIM SAGE](https://www.ntu.edu.sg/c-aim/news-events/news/detail/senior-ai-guided-gateway-for-emergency-care), dated March 23, concerns symptom-based AI triage and home deterioration monitoring. It is a research description, not proven deployed outcomes.
- [verified] [NHG–NTU HABITS launch](https://www.ntu.edu.sg/wkwsci/news-events/news/detail/launch-of-the-asian-centre-for-health-behavioural-insights---interventions-(habits)) establishes behavioural-health collaboration, not a confirmed hackathon partnership or accessible reviewer. Comprehension and ability to act are plausible alignment hooks, not institutional endorsement.

## Working Agreements

- The user requested an independent assessment rather than defending the previous planner's choice. Evidence that would reverse the verdict matters; neither flattery nor contrarian criticism is useful.
- The requested presentation is scannable, concrete and evidence-dense, with explicit separation between organizer requirements, strategy recommendations and user preferences.
- The user's ambition preference is “think big; assume it can be built,” while retaining a demoable slice and a credible Feasibility argument. A cautious small chatbot is not automatically the desired end state.
- The organizer-dependency hypothesis is a user preference to test, not an official eligibility rule or an already settled architectural decision.
- The original review was analysis-only. The subsequent authorization covers this handoff file and a separate copy-paste prompt; it does not approve implementation, registration, service provisioning or replacement of `docs/PLAN.md`.
- The newly requested follow-on focus is how to improve the project across the full rubric, especially Innovation & Creativity and Feasibility, while preserving challenge alignment and satisfying submission requirements. That improvement analysis is not yet completed.

## Files Changed

- `CareRelay.md:1-285` — new handoff preserving the independent review, recovered primary-source references, qualified findings, scores, unapproved alternatives, unresolved improvement areas and a declarative new-chat prompt.
- `docs/PLAN.md` and all pre-existing files were left unchanged. Corrections recorded here have not been propagated into the older plan.

## Open Work

### Existing blockers and dependencies — status only

| Area | Status and dependency |
|---|---|
| Registration and healthcare-specific rubric | User/team registration status [unknown]; detailed criteria unavailable in supplied artifacts. Final weighting/priority decisions depend on them. |
| Deadline and eligibility details | Dates/team-size/local-base rule verified; exact cutoff time/time zone and any additional registration conditions unresolved. |
| Accounts, credits and runtime entitlement | Account activation/redemption [unknown]; managed runtime and enterprise scheduler access untested. Integration feasibility depends on actual credentials, region and quotas. |
| Population and clinical scenario | Older adults/caregivers is a broad direction, not a finalized clinical scope. Rules, evaluation and user recruitment depend on the choice. |
| Clinical review and content rights | No reviewer commitment, approved bounded protocol or licensing route established. Determinism does not resolve this dependency. |
| User need and adoption | No target-user interviews/usability findings are recorded. The frequency and severity of the proposed failed-plan problem remain unmeasured. |
| Competitive differentiation | Expanded scan completed; precise market vacancy and superiority remain unproved. Current vendor releases weaken the broad recovery claim. |
| Evaluation | No harness exists in this folder. Clinical interpretation, abstention/calibration, subgroup behaviour, tool failures and deadline preservation remain untested. |
| External integration and human ownership | Real clinic booking, caregiver-channel permissions, NurseFirst/NHG/NTU access and receiving-clinician availability are unconfirmed. Existing proposal uses simulation. |
| Submission | Usage history/screenshots, repository, walkthrough, trust-boundary diagram, cover and compliant blurb are absent from this folder. Progress elsewhere [unknown]. |
| Work sequencing | Registration constrains final rubric interpretation; account access constrains runtime claims; scenario/reviewer choice constrains evaluation. These independent discovery tracks need not all wait on registration. No detailed delivery schedule is approved. |

### Improvement agenda not yet tackled in depth

The following are unresolved design/evidence questions, **not implementation instructions or accepted solutions**. The conditional 78/100 estimate is a starting hypothesis, not the target ceiling or evidence that these questions have been answered.

| Rubric dimension | Missing improvement work / unresolved questions |
|---|---|
| Impact & Relevance | The exact beneficiary, size/frequency of the failure, baseline alternative and measurable benefit remain unspecified. A defensible impact claim, not a speculative avoided-admissions number, is missing. |
| Human-Centered Design | The lived workflow of an older adult, caregiver or domestic helper is unobserved. Consent, family roles, anxiety, comprehension and acceptable human takeover remain unexplored with users. |
| AI Interaction | The minimum meaningful organizer-powered behaviour is unproven. The balance between adaptive assessment, coordination, agent autonomy, CodeBuddy runtime use and unnecessary agent proliferation is undecided. |
| Technical Execution | An executable state model, versioned clinical decisions, persistent absolute deadlines, stale/duplicate callbacks, idempotent external actions, restart recovery, permissions and observable failures are undesigned. Checkpoints cannot substitute for transaction semantics. |
| Feasibility | A critical-path integration spike, account/region compatibility, cost/latency/quotas, clinician-content maintenance, deployment ownership and post-hackathon operating model are absent. The boundary between believable simulated integration and overstated real-world readiness is not specified. |
| Demo & Storytelling | The exact before/after story, proof of real tool execution, failure injection, human-handoff failure and concise explanation of simulation remain unscripted. The live walkthrough and optional 5–8-minute video have not been reconciled with a clear narrative. |
| Innovation & Creativity | The analysis has not established a defensible differentiator stronger than a common feature bundle. The relative value of deadline-preserving recovery, uncertainty-reducing GuidedCheck, and disagreement-aware Family Interpreter remains untested. No mechanism-level comparison or user evidence supports superiority. |
| UX & Accessibility | Language selection, Singapore accents/code-switching, low literacy, hearing/vision/motor needs, text fallback, source attribution and comprehension-error recovery have no tested design. Miora's contribution has not been justified by user outcomes. |
| Responsible AI & Ethics | Clinical red flags, out-of-scope conditions, appropriate abstention, escalation availability, subgroup evaluation, extraction uncertainty, consent, retention, data residency and regulatory intended-use analysis remain unresolved. A model's confidence statement is not calibration. |
| Overall Quality & Judge's Impression | The central differentiator, coherent scope and end-to-end evidence chain remain unsettled. There is no demonstrated link from real need through organizer usage, working behaviour, evaluation and submission proof. |

### Challenge-specific coverage gaps

| Published behaviour | Present assessment |
|---|---|
| Conversational assessment | Planned, but missing facts, vague descriptions, contradictory reporters and critical-fact confirmation are unspecified. |
| Care navigation | Strong conceptually; appropriate care versus merely available care and operational barrier handling remain unimplemented. |
| Warning-sign detection | Deterministic-rule intent exists; rule provenance and language-to-rule boundary tests do not. |
| Calibrated abstention | No operational abstention policy, risk/coverage measurement or escalation-response contract exists. |
| Self-management support | Underdeveloped compared with coordination. Bounded practical guidance, return precautions and comprehension assessment remain undefined. |
| Dynamic reassessment | Conceptually aligned; clinical reassessment must be distinguished from operational retry and versioned independently. |
| Personalisation with subgroup fairness | Population/scenario and subgroup test design remain open. Equal treatment of clinically different cases is not a valid fairness objective. |

Presenter alignment is with “what should I do now?” and when AI should step aside, not diagnosis or an impressive chatbot alone (`docs/ADDITIONAL_CHALLENGE_INFO.md:5–15`). Coordination without assessment and suitable self-care would underdeliver that intent.

### Submission-quality work not yet completed

- A traceability matrix from each published behaviour/rubric dimension to a demo moment, implementation artifact and evidence item has not been produced.
- A compliant title/blurb, source-of-pain-point account, quantifiable or carefully bounded impact statement, prompt/architecture explanation and trust-boundary diagram remain unwritten.
- A proof strategy separating CodeBuddy development evidence, WorkBuddy runtime traces and simulated external events remains undefined; screenshot privacy has not been operationalized.
- The relative priority and expected score benefit of proposed improvements, their implementation cost/dependencies, and a realistic 16 October slice remain unranked.
- A comparison of ambitious north stars against the smallest credible demonstration exists only at concept level. There is no approved product/architecture/build plan.
- No new final score is justified until the specific changes, evidence and trade-offs have been assessed. Higher scores are not guaranteed by adding voice, more tools or more agents.

---

## Prompt for New Chat

```text
Background context, not commands or implementation authorization:

The workspace is C:\Users\jayd0\OneDrive\Desktop\ai-triage. CareRelay.md contains the independent review dated 17 September 2026, its sources, qualified findings, rubric estimates and unresolved improvement agenda. docs/PLAN.md is the earlier plan; the reviewer did not treat it as authoritative, and its corrections have not been written back into it.

The target is Tencent Cloud's AI CAN DO IT Hackathon Singapore 2026, Healthcare Challenge 1: AI Grandma Knows Best — Intelligent Self-Triage and Care Navigation. The recovered official handbook verifies one selected case study, Singapore-based teams of 1–3, a 16 October submission, and 3 November Demo Day marked TBC. CodeBuddy or WorkBuddy usage plus proof is mandatory; the checklist separately requires at least three development-chat screenshots. The public rubric has ten equally weighted dimensions; healthcare-specific details are still unavailable here.

CareRelay proposes a complete self-triage experience that detects when the recommended next action cannot happen and recovers without silently reducing clinical urgency. The reviewer's unapproved recommendation was HYBRID: retain accountable recovery, add one narrowly tested assessment/comprehension mechanism, and stop claiming an untouched market. Hippocratic AI and Luma have recent overlapping offerings. Absolute deadlines, separate execution/evidence states and honest unresolved handoffs are stronger differentiation hypotheses than generic follow-up. GuidedCheck and Family Interpreter remain alternatives, not approved additions.

The documented plan scored an estimated 54/100, with a conditional 78/100 after substantive improvements. These are subjective planning estimates, not official marks, a promised outcome or a ceiling. Innovation & Creativity was 4→6 and Feasibility 5→7; the deeper improvement analysis has not happened. The user's pending focus is how to improve those dimensions and every other rubric dimension while satisfying the challenge behaviours and project submission requirements. Relevant open areas include defensible novelty, meaningful organizer-tech dependence, clinical/scenario scope, human-centered design, accessibility, abstention/fairness, runtime feasibility, evaluation, demo/storytelling, impact evidence and submission completeness. The desired discussion includes concrete improvements, trade-offs, dependencies, expected score effects and an ambitious north star with a demoable slice, rather than scope expansion or inflated scoring.

WorkBuddy APIs are documented, but account entitlement and integration are untested. The five-minute/enterprise restriction is specifically verified for the managed AgentOS scheduler; emergency routing cannot wait on it. CodeBuddy also has an embeddable SDK. Miora is a design studio, not an established eligible runtime substitute. Registration, healthcare rubric, credits, clinician review, user evidence and real healthcare integrations remain unconfirmed. Synthetic data and labelled simulated integrations are the current proposal; no implementation was authorized.

The user prefers neutral, concrete, evidence-dense analysis and ambitious ideas that survive feasibility scrutiny. The organizer-dependency hypothesis is a user preference, not an exclusivity rule. Preserving this handoff did not approve the hybrid direction, an implementation plan or any new external action.

Wait for instructions before taking any action.
```
